Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy

Cell Death and Differentiation

Volumn 22, Issue 11, 2015, Pages 1764-1774

  Golomb, L ^a   Sagiv, A ^a   Pateras, I S ^b   Maly, A ^c   Krizhanovsky, V ^a   Gorgoulis, V G ^d,e,f,g   Oren, M ^a   Ben Yehuda, A ^c  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF ATHENS   (Greece)

^c HEBREW UNIVERSITY   (Israel)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CYTOKERATIN 10; CYTOKERATIN 14; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 20; INTERLEUKIN 24; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; OSTEOPONTIN; RAS PROTEIN; STAT6 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL AGING; CONTROLLED STUDY; EPIDERMAL STEM CELL; GENE EXPRESSION; IMMUNE EVASION; INFLAMMATION; KERATINOCYTE; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CARCINOMA; T LYMPHOCYTE; TH2 CELL; AGING; ANIMAL; CELL TRANSFORMATION; GENETICS; METABOLISM; ONCOGENE RAS; PATHOLOGY; PHYSIOLOGY; SKIN TUMOR;

AGING; ANIMALS; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; INFLAMMATION; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 84943199949     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.21     Document Type: Article

References (74)

1. Campisi J. Aging, cellular senescence, and cancer. Ann Rev Physiol 2013; 75: 685-705.
2. Serrano M, Blasco MA. Cancer and ageing: convergent and divergent mechanisms. Nat Rev Mol Cell Biol 2007; 8: 715-722.
3. Malaguarnera G, Giordano M, Cappellani A, Berretta M, Malaguarnera M, Perrotta RE. Skin cancers in elderly patients. Anticancer Agents Med chem 2013; 13: 1406-1411.
4. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344: 975-983.
5. Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Invest 2007; 117: 1137-1146.
6. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R et al. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001; 294: 605-609.
7. McElhaney JE, Effros RB. Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immun 2009; 21: 418-424.
8. Finkel T, Serrano M, Blasco MA. The common biology of cancer and ageing. Nature 2007; 448: 767-774.
9. Fulop T, Larbi A, Witkowski JM, Kotb R, Hirokawa K, Pawelec G. Immunosenescence and cancer. Crit Rev Oncog 2013; 18: 489-513.
10. Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest 2013; 123: 958-965.
11. Lynch HE, Goldberg GL, Chidgey A, Van den Brink MR, Boyd R, Sempowski GD. Thymic involution and immune reconstitution. Trends Immunol 2009; 30: 366-373.
12. Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA 2005; 102: 9194-9199.
13. Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, Rossi DJ et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci USA 2011; 108: 20012-20017.
14. Maue AC, Yager EJ, Swain SL, Woodland DL, Blackman MA, Haynes L. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol 2009; 30: 301-305.
15. Chou JP, Effros RB. T cell replicative senescence in human aging. Curr Pharm Des 2013; 19: 1680-1698.
16. Effros RB. Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev Comp Immunol 1997; 21: 471-478.
17. Montes CL, Chapoval AI, Nelson J, Orhue V, Zhang X, Schulze DH et al. Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion. Cancer Res 2008; 68: 870-879.
18. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-899.
19. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 2011; 12: 715-723.
20. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
21. Hu B, Castillo E, Harewood L, Ostano P, Reymond A, Dummer R et al. Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling. Cell 2012; 149: 1207-1220.
22. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
23. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N YAcad Sci 2000; 908: 244-254.
24. Sikora E, Bielak-Zmijewska A, Mosieniak G. Cellular senescence in ageing, age-related disease and longevity. Curr Vasc Pharmacol 2013; 12: 698-706.
25. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5: 99-118.
26. Doles J, Storer M, Cozzuto L, Roma G, Keyes WM. Age-associated inflammation inhibits epidermal stem cell function. Genes Dev 2012; 26: 2144-2153.
27. Blanpain C. Tracing the cellular origin of cancer. Nat Cell Biol 2013; 15: 126-134.
28. Tarutani M, Cai T, Dajee M, Khavari PA. Inducible activation of Ras and Raf in adult epidermis. Cancer Res 2003; 63: 319-323.
29. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
30. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J et al. PGC-1alpharesponsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.
31. Hummerich L, Muller R, Hess J, Kokocinski F, Hahn M, Furstenberger G et al. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development. Oncogene 2006; 25: 111-121.
32. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593-602.
33. Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science 2008; 319: 1352-1355.
34. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001; 98: 12072-12077.
35. Tremain R, Marko M, Kinnimulki V, Ueno H, Bottinger E, Glick A. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras. Oncogene 2000; 19: 1698-1709.
36. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6: 2853-2868.
37. Kansara M, Leong HS, Lin DM, Popkiss S, Pang P, Garsed DW et al. Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation. J Clin Invest 2013; 123: 5351-5360.
38. Weng H, Deng Y, Xie Y, Liu H, Gong F. Expression and significance of HMGB1, TLR4 and NF-kappaB p65 in human epidermal tumors. BMC Cancer 2013; 13: 311.
39. Mittal D, Saccheri F, Venereau E, Pusterla T, Bianchi ME, Rescigno M. TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J 2010; 29: 2242-2252.
40. Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, Geha RS. IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 2003; 112: 1058-1066.
41. Choi JP, Kim YS, Kim OY, Kim YM, Jeon SG, Roh TY et al. TNF-alpha is a key mediator in the development of Th2 cell response to inhaled allergens induced by a viral PAMP doublestranded RNA. Allergy 2012; 67: 1138-1148.
42. Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is downregulated by Th2 cytokines through STAT-6. Clin Immunol 2008; 126: 332-337.
43. Howell MD, Fairchild HR, Kim BE, Bin L, Boguniewicz M, Redzic JS et al. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008; 128: 2248-2258.
44. Shurin MR, Lu L, Kalinski P, Stewart-Akers AM, Lotze MT. Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 1999; 21: 339-359.
45. Bosco A, McKenna KL, Devitt CJ, Firth MJ, Sly PD, Holt PG. Identification of novel Th2-associated genes in T memory responses to allergens. J Immunol 2006; 176: 4766-4777.
46. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006; 177: 7303-7311.
47. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12: 252-264.
48. Belai EB, de Oliveira CE, Gasparoto TH, Ramos RN, Torres SA, Garlet GP et al. PD-1 blockage delays murine squamous cell carcinoma development. Carcinogenesis 2014; 35: 424-431.
49. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134: 657-667.
50. Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011; 479: 547-551.
51. Lien WH, Guo X, Polak L, Lawton LN, Young RA, Zheng D et al. Genome-wide maps of histone modifications unwind in vivo chromatin states of the hair follicle lineage. Cell Stem Cell 2011; 9: 219-232.
52. Cotsarelis G. Epithelial stem cells: a folliculocentric view. J Invest Dermatol 2006; 126: 1459-1468.
53. Quintanilla M, Brown K, Ramsden M, Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 1986; 322: 78-80.
54. Lapouge G, Youssef KK, Vokaer B, Achouri Y, Michaux C, Sotiropoulou PA et al. Identifying the cellular origin of squamous skin tumors. Pro Natl Acad Sci USA 2011; 108: 7431-7436.
55. Ren ZP, Ahmadian A, Ponten F, Nister M, Berg C, Lundeberg J et al. Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. Am J Pathol 1997; 150: 1791-1803.
56. Butani AK, Arbesfeld DM, Schwartz RA. Premalignant and early squamous cell carcinoma. Clin Plast Surg 2005; 32: 223-235.
57. Spencer JM, Kahn SM, Jiang W, DeLeo VA, Weinstein IB. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 1995; 131: 796-800.
58. de Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005; 7: 411-423.
59. Briso EM, Guinea-Viniegra J, Bakiri L, Rogon Z, Petzelbauer P, Eils R et al. Inflammationmediated skin tumorigenesis induced by epidermal c-Fos. Genes Dev 2013; 27: 1959-1973.
60. Wilson ML, Elston DM, Tyler WB, Marks VJ, Ferringer T. Dense lymphocytic infiltrates associated with non-melanoma skin cancer in patients with chronic lymphocytic leukemia. Dermatol Online J 2010; 16: 4.
61. Di Piazza M, Nowell CS, Koch U, Durham AD, Radtke F. Loss of cutaneous TSLPdependent immune responses skews the balance of inflammation from tumor protective to tumor promoting. Cancer Cell 2012; 22: 479-493.
62. Mansfield AS, Nevala WK, Dronca RS, Leontovich AA, Shuster L, Markovic SN. Normal ageing is associated with an increase in Th2 cells, MCP-1 (CCL1) and RANTES (CCL5), with differences in sCD40L and PDGF-AA between sexes. Clin Exp Immunol 2012; 170: 186-193.
63. Mirza N, Pollock K, Hoelzinger DB, Dominguez AL, Lustgarten J. Comparative kinetic analyses of gene profiles of naive CD4+ and CD8+ T cells from young and old animals reveal novel age-related alterations. Aging Cell 2011; 10: 853-867.
64. de Souza Jr DA, Toso VD, Campos MR, Lara VS, Oliver C, Jamur MC. Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression. PloS One 2012; 7: e40790.
65. Ch'ng S, Wallis RA, Yuan L, Davis PF, Tan ST. Mast cells and cutaneous malignancies. Mod Pathol 2006; 19: 149-159.
66. Siebenhaar F, Metz M, Maurer M. Mast cells protect from skin tumor development and limit tumor growth during cutaneous de novo carcinogenesis in a Kit-dependent mouse model. Exp Dermatol 2014; 23: 159-164.
67. Biswas SK, Allavena P, Mantovani A. Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin Immunopathol 2013; 35: 585-600.
68. Freije A, Ceballos L, Coisy M, Barnes L, Rosa M, De Diego E et al. Cyclin E drives human keratinocyte growth into differentiation. Oncogene 2012; 31: 5180-5192.
69. Tokarsky-Amiel R, Azazmeh N, Helman A, Stein Y, Hassan A, Maly A et al. Dynamics of senescent cell formation and retention revealed by p14ARF induction in the epidermis. Cancer Res 2013; 73: 2829-2839.
70. Vallejo AN, Weyand CM, Goronzy JJ. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med 2004; 10: 119-124.
71. Meloni F, Morosini M, Solari N, Passadore I, Nascimbene C, Novo M et al. Foxp3 expressing CD4+ CD25+ and CD8+CD28-Tregulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol 2006; 67: 1-12.
72. Ye SW, Wang Y, Valmori D, Ayyoub M, Han Y, Xu XL et al. Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin content. J Clin Immunol 2006; 26: 447-456.
73. Effros RB. The role of CD8 T cell replicative senescence in human aging. Discov Med 2005; 5: 293-297.
74. Sagiv A, Biran A, Yon M, Simon J, Lowe SW, Krizhanovsky V. Granule exocytosis mediates immune surveillance of senescent cells. Oncogene 2013; 32: 1971-1977.